Roshawn Blunt, Managing Director, 1798, a Fingerpaint company
Roshawn Blunt, 1798, a Fingerpaint company, talks about the unique commercialization challenges gene and cell therapy companies face with Taren Grom from PharmaVOICE.
Kathleen Mandziuk, MPH, RN, Vice President of Digital Health, PRA Health Sciences
Christina Fawcett, Senior Director of Operations in Real World Solutions, Digital Health, PRA Health Sciences
Dinesh Kasthuril, Head of Global Client Relations & Project Management, Patient Safety Solutions, Covance
J.P. Maranzani, VP, Account Group Supervisor - Point of Care Practice (EHR/ABM), Ogilvy Health
Roshawn Blunt, Managing Director, 1798, a Fingerpaint company
